La dépression

Accueil
Contenus
La dépression

Accueil
Contenus
La dépression

20 Déc 2023

Médical & paramédical

MANIFESTATIONS PSYCHIATRIQUES

PLAN DU CHAPITRE

1- Le fonctionnement comportemental

2- Trouble du spectre autistique

3- Le TDAH

4- La dépression

5- Régression et catatonie

6- Schizophrénie et troubles psychotiques

7- TOC et troubles apparentés

Avec le docteur Laura Cretu, psychiatre, le docteur Hervé Walti, pédiatre à l’Institut Jérôme Lejeune, nous parle, dans cette vidéo et dans la fiche technique qui l’accompagne, de la dépression chez les personnes porteuses de trisomie 21.

Découvrez l’intégralité du chapitre « Manifestations psychiatriques» en cliquant sur “Plan du chapitre” à droite de l’image en haut de l’article.

Découvrez ci-dessous la présentation associée à cette vidéo.

Ailey, S. H., Miller, A. M., Heller, T., & Smith, E. V., Jr. Evaluating an Interpersonal Model of Depression among adults with Down syndrome. Research and Theory for Nursing Practice, 2006; 20, 229–246.
Anthonio G, Malik F, Ghomeshi A, Lopez O, Gralnik L. Maintenance Electroconvulsive Therapy, Developmental Regression, Depression and Catatonia in an Adolescent With Down Syndrome: A Case Report. Cureus. 2022 Nov 26;14(11).
Aylward, E. H., Li, Q., Honeycutt, N. A., Warren, A. C., Pulsifer, M. B., Barta, P. E., et al. MRI volumes of the hippocampus and amygdala in adults with Down’s syndrome with and without dementia. American Journal of Psychiatry, 1999 ; 156, 564–568.
Byrne, C., & Seyfort, B. Complications in the diagnosis and treatment of depression in persons with Down syndrome. The NADD Bulletin, 1998; 1, 103–106.
Capone GT, Aidikoff JM, Taylor K, Natalie Rykiel N. Adolescents and young adults with Down syndrome presenting to a medical clinic with depression: Co-morbid obstructive sleep apnea. Am J Med Genet Part A 2013 ; 161A:2188–2196.
Chang C-H, Chen S-J, Liu C-Y. Pediatric sleep apnea and depressive disorders risk: A population-based 15-year retrospective cohort study. 2017; PLoS ONE 12(7): e0181430.
Collacott, R. A., & Cooper, S. A.. Adaptive behavior after depressive illness in Down’s syndrome. Journal of Nervous and Mental Disease, 1992 ; 180, 468–470.
Cooper, S. A., & Collacott, R. A. Prognosis of depression in Down’s syndrome. Journal of Nervous and Mental Disease, 1993; 181, 204–205.
Cooper, S. A., & Collacott, R. A. Clinical features and diagnostic criteria of depression in Down’s syndrome. British Journal of Psychiatry, 1994; 165, 399–403
Dykens EM, Shah B, Davis B, Baker C, Fife T, Fitzpatrick J. Psychiatric disorders in adolescents and young adults with Down syndrome and other intellectual disabilities. J Neurodev Disord. 2015;7(1):9.
Fletcher RJ, Barnhill J, Cooper S DM-ID-2 : Diagnostic manual, intellectual disability : a textbook of diagnosis of mental disorders in persons with intellectual disability. NADD Publication, 2016.
Gensheimer, P.M., Meighen, K.G. & McDougle, C.J. ECT in an Adolescent with Down Syndrome and Treatment-Refractory Major Depressive Disorder. Journal of Developmental and Physical Disabilities 2002; 14, 291–295.
Hurley A. Two Cases of Suicide Attempt by Patients With Down’s Syndrome. Psychiatric services (Washington, D.C.). 1998; 49. 1618-9. 10.1176/ps.49.12.1618.
Joffe, R. T. Is the thyroid still important in major depression? Journal of Psychiatry and Neuroscience, 2006; 31, 367–368.
Lindsay, W. R., Howells, L., & Pitcaithly, D. Cognitive therapy for depression with individuals with intellectual disabilities. British Journal of Medical Psychology, 1993; 66, 135–141.

Ludi E, Ballard ED, Greenbaum R, Pao M, Bridge J, Reynolds W, Horowitz L. Suicide risk in youth with intellectual disabilities: the challenges of screening. J Dev Behav Pediatr. 2012 Jun;33(5):431-40.
Ly M, Yu GZ, Mian A, Cramer A, Meysami S, Merrill DA, Samara A, Eisenstein SA, Hershey T, Babulal GM, Lenze EJ, Morris JC, Benzinger TLS, Raji CA. Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer’s disease, and Depression. Am J Geriatr Psychiatry. 2023 Oct;31(10):853-866.
McCabe, M. P., McGillivray, J. A., & Newton, D. C. Effectiveness of treatment programmes for depression among adults with mild/moderate intellectual disability. Journal of Intellectual Disability Research, 2006; 50, 239–247.
Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G. T., & Reiss, A. L. Neuroanatomy of Down’s syndrome: A high-resolution MRI study. American Journal of Psychiatry, 2001; 158, 1659–1665.
Protocole National de Diagnostic et de Soins (PNDS) Trisomie 21 (2020). https://www.has-sante.fr/upload/docs/application/pdf/2020-01/pnds_trisomie_21.pdf.
Rivelli A, Fitzpatrick V, Chaudhari S, Chicoine L, Jia G, Rzhetsky A, Chicoine B. Prevalence of Mental Health Conditions Among 6078 Individuals With Down Syndrome in the United States. J Patient Cent Res Rev. 2022 Jan 17;9(1):58-63.
Shadan S, Almarzooqi S, Sultan MA. Behavioral Activation (BA) in the Management of Depression in an Adolescent with Down Syndrome in Dubai. Case Rep Psychiatry. 2021 Sep 18;2021:7112034.
Seidl, R., Kaehler, S. T., Prast, H., Singewald, N., Cairns, N., Gratzer, M., et al. Serotonin (5-HT) in brains of adult patients with Down syndrome. Journal of Neural Transmission. Supplementum,1999; 57, 221–232.
Smiley, E., & Cooper, S. A. Intellectual disabilities, depressive episode, diagnostic criteria and Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD). Journal of Intellectual Disability Research, 2003; 47, 62–71
Startin CM, D’Souza H, Ball G, Hamburg S, Hithersay R, Hughes KMO, Massand E, Karmiloff-Smith A, Thomas MSC; LonDownS Consortium; Strydom A. Health comorbidities and cognitive abilities across the lifespan in Down syndrome. J Neurodev Disord. 2020 Jan 23;12(1):4
Thom RP, Palumbo ML, Thompson C, McDougle CJ, Ravichandran CT. Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study. Brain Sci. 2021 Sep 15;11(9):1216.
Whittle, N., Sartori, S. B., Dierssen, M., Lubec, G., & Singewald, N. Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics, 2007 ; 120, e1465–e1471.
Willner, P. The effectiveness of psychotherapeutic interventions for people with learning disabilities: A critical overview. Journal of Intellectual Disability Research, 2005; 49, 73–85